Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?-Reference-Cited by-同舟云学术

Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?

Published:2012-11-09 Issue:12 Volume:13 Page:14579-14605
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Jalilian Babak,Einarsson Halldór,Vorup-Jensen Thomas

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/13/11/14579/pdf

Reference156 articles.

1. Histologie de la sclerose en plaques;Charcot;Gaz. Hop,1868

2. Sustained release oral fampridine in the treatment of multiple sclerosis;Kachuck;Expert Opin. Pharmacother,2009

3. Multiple sclerosis;Compston;Lancet,2008

4. Epidemiology of multiple sclerosis: A critical overview;Sadovnick;Can. J. Neurol. Sci,1993

5. Diagnosis and management of multiple sclerosis;Calabresi;Am. Family Phys,2004

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial peptide glatiramer acetate targets Pseudomonas aeruginosa lipopolysaccharides to breach membranes without altering lipopolysaccharide modification;npj Antimicrobials and Resistance;2024-02-20

2. Potential of Nano-Engineered Stem Cells in the Treatment of Multiple Sclerosis: A Comprehensive Review;Cellular and Molecular Neurobiology;2023-12-17

3. Immune-active polymeric materials for the treatment of inflammatory diseases;Current Opinion in Colloid & Interface Science;2023-10

4. The Probable Infectious Origin of Multiple Sclerosis;NeuroSci;2023-09-07

5. Antimicrobial peptide glatiramer acetate targetsPseudomonas aeruginosalipopolysaccharides to breach membranes without altering lipopolysaccharide modification;2023-05-23